Cyrus C Szeto-Wong, MD
Cardiac Electrophysiology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Szeto-Wong’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126096 · Current
Licensed to practise in California · since 2013 · expires 2027-06-30 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$76,200
Medicare paid this office $76,200 for 1,837 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,191 | $13,754 | $7 |
| Return visit (30+ min) | 82 | $9,567 | $79 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 257 | $5,894 | $22 |
| Long return visit (40+ min) | 25 | $3,182 | $122 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 97 | $1,893 | $20 |
See all 13 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,191 | $13,754 | $7 |
| Return visit (30+ min) | 82 | $9,567 | $79 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 257 | $5,894 | $22 |
| Long return visit (40+ min) | 25 | $3,182 | $122 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 97 | $1,893 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 48 | $1,432 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,291 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 251 | $1,185 | $5 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 62 | $1,151 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,138 | $71 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 60 | $1,131 | $19 |
| Short return visit (20+ min) | 15 | $899 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 28 | $349 | $12 |
Procedures Medicare counted
| Pacemaker insertion or repair | 12 | More than 63% of doctors who do this |
Who their Medicare patients are
1,837 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 15% · Women 52% · Also on Medicaid 76% · Health risk score 2.12. Above the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 37% · Heart failure 35% · Atrial fibrillation 33% · Chronic kidney disease 31% · Depression 24% · COPD 19% · Stroke 17% · Dementia 16% · Cancer 14%.
The office billed $966,873, Medicare allowed $101,481 and paid $76,200; for 3,142 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,837 | 3,142 | 73 | 2.12 | $966,873 | $76,200 |
| 2023 | 1,517 | 2,645 | 73 | 1.98 | $770,757 | $63,031 |
| 2022 | 1,150 | 2,031 | 74 | 1.80 | $437,246 | $52,227 |
| 2021 | 642 | 2,205 | 78 | 1.86 | $502,794 | $152,972 |
| 2020 | 570 | 1,935 | 78 | 1.94 | $366,730 | $109,986 |
| 2019 | 564 | 2,183 | 77 | 2.08 | $526,520 | $151,856 |
| 2018 | 430 | 1,669 | 77 | 2.24 | $423,249 | $122,544 |
| 2017 | 394 | 1,325 | 77 | 2.24 | $353,520 | $108,082 |
| 2016 | 152 | 543 | 77 | 1.52 | $145,150 | $46,893 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 977 | $11,026 | $7 |
| Return visit (30+ min) | 91 | $9,793 | $81 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 150 | $3,661 | $23 |
| Short return visit (20+ min) | 52 | $2,406 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 126 | $1,746 | $13 |
| Long return visit (40+ min) | 15 | $1,724 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,495 | $125 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 45 | $1,323 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,286 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $785 | $5 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 47 | $724 | $14 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 34 | $715 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $610 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 55 | $582 | $11 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $579 | $34 |
| Short return visit | 20 | $490 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $449 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $383 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $270 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 16 | $91 | $6 |
2022: 17 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 593 | $6,637 | $7 |
| Return visit (30+ min) | 68 | $5,622 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 93 | $5,550 | $23 |
| Return visit (30+ min) | 51 | $4,468 | $81 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $2,448 | $31 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 113 | $1,842 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 73 | $1,786 | $24 |
| Short return visit (20+ min) | 25 | $1,496 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 57 | $803 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 119 | $629 | $5 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $527 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 27 | $481 | $18 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $408 | $34 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $404 | $22 |
| Short return visit | 11 | $361 | $33 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 29 | $244 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $132 | $7 |
2021: 28 services
| Return visit (30+ min) | 255 | $38,702 | $100 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 17 | $15,061 | $886 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 127 | $8,778 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,283 | $436 |
| Long return visit (40+ min) | 41 | $7,026 | $146 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 27 | $6,257 | $232 |
| New patient visit (45+ min) | 38 | $5,221 | $137 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 12 | $4,314 | $332 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,200 | $156 |
| New patient visit (60+ min) | 21 | $4,040 | $192 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 49 | $3,969 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,385 | $106 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 161 | $2,961 | $12 |
| Programming of dual lead pacemaker system | 68 | $2,867 | $30 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 119 | $2,660 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,165 | $56 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 17 | $1,645 | $97 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 20 | $1,140 | $20 |
| Short return visit (20+ min) | 12 | $1,031 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $969 | $7 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 76 | $925 | $12 |
| Programming of multiple lead implantable defibrillator system | 11 | $898 | $53 |
| Programming of dual lead implantable defibrillator system | 11 | $822 | $43 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $806 | $32 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $450 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $433 | $10 |
| Programming of single lead implantable defibrillator system | 11 | $365 | $28 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $216 | $20 |
2020: 24 services
| Return visit (30+ min) | 232 | $26,486 | $77 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $11,926 | $442 |
| Long return visit (40+ min) | 45 | $6,583 | $120 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 128 | $6,218 | $25 |
| Telephone medical discussion with physician, 5-10 minutes | 140 | $4,569 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,422 | $158 |
| New patient visit (45+ min) | 25 | $3,539 | $142 |
| New patient visit (60+ min) | 21 | $3,307 | $157 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 48 | $2,945 | $31 |
| Programming of dual lead pacemaker system | 76 | $2,769 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 132 | $2,439 | $13 |
| Short return visit (20+ min) | 33 | $2,039 | $54 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 92 | $2,034 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,975 | $116 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $1,903 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,282 | $61 |
| Programming of multiple lead implantable defibrillator system | 15 | $1,188 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 121 | $946 | $7 |
| Programming of dual lead implantable defibrillator system | 12 | $748 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $425 | $10 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 36 | $415 | $11 |
| Programming of single lead implantable defibrillator system | 11 | $334 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $324 | $23 |
| Evaluation of cardiac rhythm monitor system | 11 | $142 | $13 |
2019: 26 services
| Return visit (30+ min) | 221 | $32,062 | $85 |
| Insertion of implantable defibrillator system | 16 | $12,202 | $763 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $11,404 | $407 |
| Short return visit (20+ min) | 175 | $10,799 | $49 |
| Long return visit (40+ min) | 65 | $8,816 | $116 |
| Programming of dual lead pacemaker system | 129 | $6,767 | $28 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,584 | $161 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 176 | $4,046 | $14 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 18 | $4,042 | $225 |
| New patient visit (45+ min) | 27 | $3,506 | $130 |
| New patient visit (60+ min) | 16 | $2,605 | $163 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 114 | $2,440 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 61 | $2,013 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $1,863 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,807 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,582 | $79 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $1,449 | $121 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 156 | $1,291 | $7 |
| Programming of dual lead implantable defibrillator system | 17 | $1,279 | $43 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,218 | $47 |
| Programming of single lead implantable defibrillator system | 24 | $1,190 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,090 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 54 | $566 | $10 |
| Programming of single lead pacemaker system | 11 | $464 | $27 |
| Evaluation of cardiac rhythm monitor system | 18 | $308 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $289 | $22 |
2018: 20 services
| Return visit (30+ min) | 135 | $16,374 | $80 |
| Short return visit (20+ min) | 183 | $14,042 | $56 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $11,911 | $411 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $8,805 | $629 |
| Long return visit (40+ min) | 49 | $6,573 | $115 |
| Programming of dual lead pacemaker system | 111 | $6,078 | $30 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 20 | $5,540 | $264 |
| New patient visit (60+ min) | 31 | $4,877 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,603 | $153 |
| New patient visit (45+ min) | 27 | $3,258 | $121 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 143 | $2,941 | $14 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 74 | $1,622 | $21 |
| Programming of single lead implantable defibrillator system | 21 | $1,251 | $32 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,238 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 129 | $1,195 | $7 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,080 | $49 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $591 | $30 |
| Programming of single lead pacemaker system | 12 | $536 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $519 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $207 | $19 |
2017: 21 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $15,491 | $419 |
| Return visit (30+ min) | 110 | $13,847 | $85 |
| Insertion of implantable defibrillator system | 15 | $10,866 | $724 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,174 | $162 |
| Short return visit (20+ min) | 90 | $5,545 | $56 |
| Long return visit (40+ min) | 38 | $5,354 | $119 |
| Programming of dual lead pacemaker system | 93 | $4,067 | $33 |
| New patient visit (60+ min) | 24 | $4,047 | $169 |
| New patient visit (45+ min) | 31 | $3,526 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,522 | $110 |
| New patient visit (30+ min) | 25 | $2,163 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | $1,739 | $13 |
| Programming of single lead implantable defibrillator system | 22 | $1,671 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,278 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 119 | $1,254 | $7 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $844 | $31 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 35 | $749 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $431 | $10 |
| External ekg recording for more than 48 hours up to 21 days | 13 | $349 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $310 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $307 | $20 |
2016: 8 services
| Return visit (30+ min) | 45 | $5,725 | $88 |
| Short return visit (20+ min) | 60 | $4,893 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,635 | $73 |
| Long return visit (40+ min) | 17 | $2,435 | $116 |
| New patient visit (45+ min) | 15 | $1,943 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 74 | $1,774 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,555 | $111 |
| Programming of dual lead pacemaker system | 19 | $1,078 | $38 |
Medicaid work
$16,940 in 2024
Medicaid paid $16,940 for 7,328 billed services this clinician did in 2024, up to 492 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5,444 | $13,216 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 582 | $1,097 |
| Return visit (30+ min) | 195 | $1,045 |
| External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation | 276 | $967 |
| XTRNL ECG REC<48 HR R&I | 81 | $333 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 85 | $116 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 90 | $109 |
| XTRNL ECG REC<48 HRS REC | 28 | $54 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 13 | $4 |
| Pain severity quantified; no pain present (COA) (ONC) | 19 | $0 |
| Medication list documented in medical record (COA) | 219 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 83 | $0 |
| 2024 | 7,328 | 16 | 492 | $16,940 |
| 2023 | 7,112 | 14 | 364 | $17,627 |
| 2022 | 2,376 | 7 | 243 | $8,838 |
| 2021 | 60 | 2 | 16 | $1,168 |
| 2020 | 31 | 1 | 15 | $155 |
| 2019 | 129 | 2 | 16 | $2,985 |
| 2018 | 36 | 1 | 13 | $238 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5,302 | $13,141 |
| Return visit (30+ min) | 205 | $1,242 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 517 | $1,130 |
| XTRNL ECG REC<48 HR R&I | 580 | $1,002 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 81 | $477 |
| Short return visit (20+ min) | 70 | $253 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 85 | $202 |
| External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation | 83 | $124 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 26 | $22 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 13 | $21 |
| XTRNL ECG REC<48 HRS REC | 92 | $13 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 14 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,884 | $6,755 |
| XTRNL ECG REC<48 HR R&I | 285 | $1,434 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 92 | $249 |
| Return visit (30+ min) | 27 | $224 |
| XTRNL ECG REC<48 HRS REC | 62 | $118 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $59 |
| Short return visit (20+ min) | 14 | $0 |
2021
| Return visit (30+ min) | 19 | $973 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 41 | $195 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 31 | $155 |
2019
| Return visit (30+ min) | 62 | $2,661 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 67 | $324 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 36 | $238 |
Drugs they prescribed that Part D paid
$113,447
Pharmacies billed $113,447 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 475) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
339 generic and 136 brand-name prescriptions · $113,447 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 108 | $81,379 | $754 |
| Xarelto | 16 | $13,629 | $852 |
| Diltiazem 12hr Er | 12 | $2,599 | $217 |
| Amiodarone | 102 | $1,262 | $12 |
| Flecainide Acetate | 44 | $829 | $19 |
See all 8 drugs
| Eliquis | 108 | $81,379 | $754 |
| Xarelto | 16 | $13,629 | $852 |
| Diltiazem 12hr Er | 12 | $2,599 | $217 |
| Amiodarone | 102 | $1,262 | $12 |
| Flecainide Acetate | 44 | $829 | $19 |
| Metoprolol | 76 | $672 | $9 |
| Furosemide | 17 | $54 | $3 |
| Metoprolol | 12 | $37 | $3 |
Year by year
| 2024 | 475 | 105 | 0% (0) | 29% | $113,447 |
| 2023 | 335 | 89 | 0% (0) | 34% | $103,596 |
| 2022 | 729 | 213 | 0% (0) | 37% | $320,323 |
| 2021 | 1,426 | 322 | None | 30% | $517,318 |
| 2020 | 1,376 | 292 | None | 30% | $458,117 |
| 2019 | 1,130 | 275 | None | None | $318,524 |
| 2018 | 801 | 193 | None | 27% | $180,571 |
| 2017 | 391 | 120 | None | 47% | $76,147 |
| 2016 | 196 | 48 | 0% (0) | 45% | $24,681 |
| 2015 | 17 | 12 | 0% (0) | None | $2,374 |
| 2014 | 25 | 17 | None | 0% | $569 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Eliquis | 103 | $79,242 | $769 |
| Diltiazem 12hr Er | 11 | $2,382 | $217 |
| Amiodarone | 47 | $2,307 | $49 |
| Flecainide Acetate | 18 | $1,344 | $75 |
| Metoprolol | 28 | $562 | $20 |
| Metoprolol | 25 | $203 | $8 |
| Furosemide | 22 | $120 | $5 |
| Doxycycline Monohydrate | 16 | $111 | $7 |
| Benazepril | 14 | $58 | $4 |
2022: 13 drugs
| Eliquis | 206 | $229,853 | $1,116 |
| Xarelto | 32 | $42,617 | $1,332 |
| Flecainide Acetate | 52 | $2,534 | $49 |
| Metoprolol | 104 | $2,347 | $23 |
| Atorvastatin | 24 | $1,900 | $79 |
| Diltiazem 24hr Er (Cd) | 30 | $1,681 | $56 |
| Propafenone | 12 | $763 | $64 |
| Amiodarone | 27 | $464 | $17 |
| Carvedilol | 19 | $221 | $12 |
| Losartan | 18 | $209 | $12 |
| Metoprolol | 27 | $149 | $6 |
| Furosemide | 20 | $71 | $4 |
| Lisinopril | 13 | $67 | $5 |
2021: 20 drugs
| Eliquis | 345 | $394,021 | $1,142 |
| Xarelto | 49 | $57,123 | $1,166 |
| Entresto | 12 | $14,692 | $1,224 |
| Metoprolol | 260 | $7,944 | $31 |
| Diltiazem 24hr Er (Cd) | 73 | $6,843 | $94 |
| Flecainide Acetate | 81 | $4,450 | $55 |
| Amiodarone | 45 | $1,072 | $24 |
| Propranolol | 19 | $898 | $47 |
| Atorvastatin | 47 | $741 | $16 |
| Propafenone | 14 | $686 | $49 |
| Carvedilol | 48 | $577 | $12 |
| Losartan | 42 | $492 | $12 |
| Diltiazem | 19 | $458 | $24 |
| Doxycycline Hyclate | 34 | $317 | $9 |
| Potassium Chloride | 13 | $281 | $22 |
| Metoprolol | 45 | $263 | $6 |
| Lisinopril | 30 | $171 | $6 |
| Furosemide | 36 | $150 | $4 |
| Clopidogrel | 20 | $128 | $6 |
| Amlodipine Besylate | 28 | $92 | $3 |
2020: 22 drugs
| Eliquis | 281 | $336,953 | $1,199 |
| Xarelto | 43 | $57,627 | $1,340 |
| Metoprolol | 237 | $8,313 | $35 |
| Diltiazem 24hr Er (Cd) | 78 | $7,082 | $91 |
| Flecainide Acetate | 50 | $3,787 | $76 |
| Amiodarone | 21 | $2,219 | $106 |
| Bumetanide | 11 | $1,198 | $109 |
| Carvedilol | 87 | $771 | $9 |
| Atorvastatin | 46 | $670 | $15 |
| Losartan | 54 | $603 | $11 |
| Isosorbide Mononitrate Er | 23 | $513 | $22 |
| Doxycycline Hyclate | 35 | $403 | $12 |
| Propafenone | 12 | $294 | $24 |
| Clopidogrel | 36 | $290 | $8 |
| Furosemide | 51 | $262 | $5 |
| Warfarin | 15 | $234 | $16 |
| Metoprolol | 39 | $215 | $6 |
| Lisinopril | 47 | $175 | $4 |
| Spironolactone | 11 | $141 | $13 |
| Atenolol | 15 | $139 | $9 |
| Amlodipine Besylate | 33 | $133 | $4 |
| Hydrochlorothiazide | 12 | $34 | $3 |
2019: 19 drugs
| Eliquis | 193 | $218,075 | $1,130 |
| Xarelto | 43 | $45,377 | $1,055 |
| Metoprolol | 179 | $6,423 | $36 |
| Flecainide Acetate | 52 | $3,585 | $69 |
| Diltiazem 24hr Er (Cd) | 50 | $2,307 | $46 |
| Amiodarone | 22 | $2,185 | $99 |
| Carvedilol | 82 | $708 | $9 |
| Cartia Xt | 17 | $634 | $37 |
| Doxycycline Hyclate | 43 | $626 | $15 |
| Losartan | 49 | $604 | $12 |
| Atorvastatin | 32 | $583 | $18 |
| Hydralazine | 11 | $319 | $29 |
| Warfarin | 20 | $298 | $15 |
| Metoprolol | 46 | $246 | $5 |
| Furosemide | 46 | $217 | $5 |
| Clopidogrel | 22 | $197 | $9 |
| Lisinopril | 34 | $153 | $5 |
| Atenolol | 18 | $128 | $7 |
| Amlodipine Besylate | 21 | $95 | $5 |
2018: 17 drugs
| Eliquis | 117 | $95,842 | $819 |
| Xarelto | 38 | $28,929 | $761 |
| Brilinta | 17 | $15,655 | $921 |
| Metoprolol | 140 | $5,505 | $39 |
| Flecainide Acetate | 33 | $1,994 | $60 |
| Amiodarone | 26 | $1,889 | $73 |
| Diltiazem 24hr Er (Cd) | 27 | $803 | $30 |
| Carvedilol | 55 | $539 | $10 |
| Doxycycline Hyclate | 29 | $506 | $17 |
| Warfarin | 31 | $438 | $14 |
| Atorvastatin | 20 | $409 | $20 |
| Clopidogrel | 13 | $252 | $19 |
| Lisinopril | 28 | $176 | $6 |
| Furosemide | 29 | $175 | $6 |
| Metoprolol | 34 | $162 | $5 |
| Losartan | 18 | $108 | $6 |
| Amlodipine Besylate | 19 | $61 | $3 |
2017: 8 drugs
| Eliquis | 80 | $42,899 | $536 |
| Xarelto | 25 | $13,327 | $533 |
| Metoprolol | 55 | $2,787 | $51 |
| Diltiazem 24hr Er | 20 | $960 | $48 |
| Flecainide Acetate | 20 | $735 | $37 |
| Doxycycline Hyclate | 28 | $616 | $22 |
| Furosemide | 22 | $85 | $4 |
| Metoprolol | 15 | $69 | $5 |
2016: 5 drugs
| Eliquis | 39 | $15,905 | $408 |
| Metoprolol | 32 | $860 | $27 |
| Doxycycline Hyclate | 13 | $380 | $29 |
| Flecainide Acetate | 14 | $372 | $27 |
| Diltiazem 24hr Er | 13 | $252 | $19 |
2014: 1 drug
| Cephalexin | 11 | $71 | $6 |
Money from drug and device companies
$200 in 2025
| 2025 | 1 | 3 | None | $200 |
| 2024 | 3 | 12 | None | $1,291 |
| 2023 | 1 | 1 | None | $26 |
| 2022 | 2 | 6 | None | $204 |
| 2021 | 2 | 29 | None | $960 |
| 2020 | 3 | 22 | None | $612 |
| 2019 | 6 | 56 | None | $3,078 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $200 | 3 payments
|
See all 3 published payments
| Medtronic | Meals · 2025-11-04 | Affera Mapping System | $13 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| Medtronic | Meals · 2025-01-08 | Cobalt Dr Mri Surescan | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,291
| Medtronic | Micra | $1,226 | 10 payments
|
| iRhythm Technologies | Zio Xt Patch | $39 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $27 | 1 payment
|
2023: $26
| Biotronik | Pk Papyrus | $26 | 1 payment
|
2022: $204
| Boston Scientific | Resonate El Icd Vr | $184 | 5 payments
|
| Biosense Webster | Carto 3 | $20 | 1 payment
|
2021: $960
| Boston Scientific | Resonate | $913 | 27 payments
|
| Biosense Webster | Carto 3 | $47 | 2 payments
|
2020: $612
| Boston Scientific | Resonate | $545 | 19 payments
|
| Biosense Webster | Visitag | $51 | 2 payments
|
| Medtronic Vascular | Claria Mri | $16 | 1 payment
|
2019: $3,078
| Medical Device Business Services | Carto 3 System | $2,066 | 7 payments
|
| Boston Scientific | Labsystem Pro | $584 | 18 payments
|
| Medtronic Vascular | Claria Mri | $300 | 26 payments
|
| Biotronik | None | $65 | 2 payments
|
| Biosense Webster | Carto 3 System | $42 | 2 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306166343
- Licence
- CA A126096, HI MD-18416California A126096: Current · expires 2027-06-30
- Trained
- Boston University School of Medicine, 2007
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 751 S Bascom Ave Ste 340, San Jose, CA, 95128
- NPI first listed
- 2010-06-01
- NPI last updated
- 2024-07-02
- NPI record certified
- 2024-07-02
This is when the NPI record was last certified, not a medical board exam.